Suppurative thrombophlebitis medical therapy

Suppurative thrombophlebitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Suppurative thrombophlebitis from other Diseases
Risk Factors
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Case Studies
Case #1
Suppurative thrombophlebitis medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Suppurative thrombophlebitis medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Suppurative thrombophlebitis medical therapy
CDC on Suppurative thrombophlebitis medical therapy
Suppurative thrombophlebitis medical therapy in the news
Blogs on Suppurative thrombophlebitis medical therapy
Directions to Hospitals Treating Suppurative thrombophlebitis
Risk calculators and risk factors for Suppurative thrombophlebitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

Overview

The mainstay of therapy for suppurative thrombophlebitis is antimicrobial therapy. Empiric therapy is administered and it includes a pharmacologic agent with activity against staphylococci as well as a pharmacologic with activity against enterobacteriaceae. The role of anticoagulation is uncertain, and it should not be routinely used.

Peripheral Vein Suppurative Thrombophlebitis

Till the blood culture results detect the targeted pathogen, empiric antibiotic therapy is given aiming to include an agent with activity against staphylococci plus an agent with activity against enterobacteriaceae.

Peripheral Vein Suppurative Thrombophlebitis ▸ Vancomycin 15 to 20 mg/kg/dose every 8 to 12 hours, not to exceed 2 g per dose x minimum of 2Wks PLUS ▸ Ceftriaxone 1 g IV daily x minimum of 2Wks

Jugular Vein Suppurative Thrombophlebitis

A beta-lactamase resistant beta-lactam antibiotic should be used in cases of jugular vein suppurative thrombophlebitis.

Jugular Vein Suppurative Thrombophlebitis ▸ Ampicillin-sulbactam 3 g every six hours x 4 Wks OR ▸ Piperacillin-tazobactam 4.5 g every six hours x 4 Wks OR ▸ Ticarcillin-clavulanate 3.1 g every six hours x 4 Wks PLUS ▸ Vancomycin 15 to 20 mg/kg/dose every 8 to 12 hours, not to exceed 2 g per dose x 4 Wks

Vena Cava Suppurative Thrombophlebitis

Vena Cava Suppurative Thrombophlebitis ▸ Vancomycin 15 to 20 mg/kg/dose every 8 to 12 hours, not to exceed 2 g per dose x 4 to 6 Wks PLUS ▸ Ceftriaxone 1 g IV daily x 4 to 6 Wks

Septic pelvic vein thrombophlebitis

• Based on the CT and MRI findings septic pelvic vein thrombophlebitis is classified into following categories for management..

• 1. Right ovarian vein thrombosis

• Preferred regimen (1): Ertapenem 1 g PO qd for 7 days AND Enoxaparin (1 mg/Kg) initially AND 3–6 months of Warfarin (INR 2.5)
• Preferred regimen (2): Gentamicin 4 mg/kg AND Ampicillin 2 g AND Clindamycin 1200 mg for 7 days AND Enoxaparin (1 mg/Kg) initially AND 3–6 months Warfarin (INR 2.5).
• Note: Repeat CT scan after 3 months. If negative, stop anticoagulation. If still positive for thrombi, anticoagulate for 3 additional months.

• 2. Pelvic branch vein thrombosis

• Preferred regimen (1): Ertapenem 1 g PO qd for 7 days AND Enoxaparin (1 mg/Kg) PO for 2 weeks
• Preferred regimen (2): Gentamicin (4 mg/kg) PO AND Ampicillin 2 g PO AND Clindamycin 1200 mg PO for 7 days AND Enoxaparin (1 mg/Kg) for 2 weeks.

• 3. Negative for pelvic thrombi

• Preferred regimen (1): Ertapenem 1 g PO qd for 7 days AND Enoxaparin (1 mg/Kg) for 1 week
• Preferred regimen (2): Gentamicin (4 mg/kg) PO qd AND Ampicillin 2 g PO qd AND Clindamycin 1200 mg PO qd for 7 days AND Enoxaparin (1 mg/Kg) PO qd for 1 weeks

References

Template:WikiDoc Sources